Simultaneous arming and structure/activity studies of natural products employing O-H insertions: an expedient and versatile strategy for natural products-based chemical genetics.
The identification of "druggable" targets is an immediate opportunity and challenge in the post-genomic era. Natural products are enduring tools for basic cellular studies and leads for identifying medically relevant protein targets. However, their use for these studies is often hampered by limited quantities and a lack of selective and mild monofunctionalization reactions. The development of selective methods that could simultaneously equip the natural product with a reactive group for subsequent conjugation to reporter tags and provide important structure-activity relationship (SAR) information, requiring only a knowledge of functional groups present in the natural product, could significantly decrease the time between bioactive natural product isolation and target identification. Herein, we report such a strategy that enables simultaneous arming and SAR studies of alcohol-containing natural products involving both chemo- and site-selective ("chemosite" selective) and site-nonselective O-H insertion reactions with rhodium carbenoids derived from alkynyl diazo acetates. This strategy was applied to a diverse set of natural products, and general guidelines for predicting chemosite selectivity were formulated. A subsequent Sharpless-Hüisgen [3 + 2] cycloaddition reaction with the appended alkyne allows for attachment of a variety of reporter tags. Using this strategy, we synthesized a novel FK506-biotin conjugate that enabled pull-down of the entire "immunosuppressive complex" including FKBP12, calcineurins A and B, and calmodulin. In addition, the potential for a chemoselective but site-nonselective process was shown with both gibberellic acid methyl ester and brefeldin A using only achiral rhodium catalysts.
Peddibhotla
Satyamaheshwar
S
Department of Chemistry, Texas A&M University, College Station, Texas 77842-3092, USA.
Dang
Yongjun
Y
Liu
Jun O
JO
Romo
Daniel
D
D000438:Alcohols / Q000737:chemistry* / Q000494:pharmacology*; D000480:Alkynes / Q000737:chemistry; D001688:Biological Products / Q000737:chemistry* / Q000494:pharmacology*; D001710:Biotin / Q000737:chemistry; D020126:Brefeldin A / Q000737:chemistry / Q000494:pharmacology; D003500:Cyclization; D004952:Esters / Q000737:chemistry; D005563:Formic Acid Esters / Q000737:chemistry; D005875:Gibberellins / Q000737:chemistry / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D019169:Jurkat Cells; D009942:Organometallic Compounds / Q000737:chemistry / Q000494:pharmacology; D004364:Pharmaceutical Preparations / Q000737:chemistry; D012238:Rhodium / Q000737:chemistry; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D016559:Tacrolimus / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology
D000438:Alcohols; D000480:Alkynes; D001688:Biological Products; D004952:Esters; D005563:Formic Acid Esters; D005875:Gibberellins; D009942:Organometallic Compounds; D004364:Pharmaceutical Preparations; D020126:Brefeldin A; D001710:Biotin; C007842:gibberellic acid; D012238:Rhodium; D016559:Tacrolimus